• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
  • Test Link
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Special Reports
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Google
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Special Reports
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Google
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
  • Test Link
Brought to you by:
sino biological

Cell & Gene Therapy

Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Hong Kong Stock Exchange
Biotech

Why US biotech Axiom is starting its IPO journey in Hong Kong

The move follows a phase 1 data drop on Axiom's lead stem cell therapy in the treatment of two fatal newborn neurological diseases.
Marissa Russo Jul 21, 2026 7:02am
Knee arthritis osteoarthritis

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Jul 20, 2026 9:25am
Jennifer Doudna arriving at the laureates Get together at the Nobel Prize Museum in Stockholm on 6 December 2022

Nobel Laureate Jennifer Doudna enters AI protein design arena

Brought to you by AbbVie
JNJ

J&J axes eye disease gene therapy after key phase 2b readout

Jul 15, 2026 10:26am
doctor taking umbilical cord from tube

Axiom hopes it ‘solved 2 major potholes’ for stem cell biotechs

Brought to you by Catalent
Hand with tweezers editing DNA

ARPA-H awards up to $160M for custom genetic medicines

Jul 10, 2026 4:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings